Lonza Group Ltd (LZAGY)
62.99
+1.32
(+2.14%)
USD |
OTCM |
Nov 01, 16:00
Lonza Group Price to Book Value: 4.367 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 4.367 |
| October 31, 2024 | 4.275 |
| October 30, 2024 | 4.287 |
| October 29, 2024 | 4.336 |
| October 28, 2024 | 4.406 |
| October 25, 2024 | 4.431 |
| October 24, 2024 | 4.445 |
| October 23, 2024 | 4.316 |
| October 22, 2024 | 4.327 |
| October 21, 2024 | 4.336 |
| October 18, 2024 | 4.426 |
| October 17, 2024 | 4.402 |
| October 16, 2024 | 4.292 |
| October 15, 2024 | 4.301 |
| October 14, 2024 | 4.361 |
| October 11, 2024 | 4.255 |
| October 10, 2024 | 4.213 |
| October 09, 2024 | 4.284 |
| October 08, 2024 | 4.266 |
| October 07, 2024 | 4.254 |
| October 04, 2024 | 4.262 |
| October 03, 2024 | 4.325 |
| October 02, 2024 | 4.329 |
| October 01, 2024 | 4.392 |
| September 30, 2024 | 4.379 |
| Date | Value |
|---|---|
| September 27, 2024 | 4.418 |
| September 26, 2024 | 4.436 |
| September 25, 2024 | 4.340 |
| September 24, 2024 | 4.390 |
| September 23, 2024 | 4.375 |
| September 20, 2024 | 4.334 |
| September 19, 2024 | 4.435 |
| September 18, 2024 | 4.361 |
| September 17, 2024 | 4.406 |
| September 16, 2024 | 4.536 |
| September 13, 2024 | 4.536 |
| September 12, 2024 | 4.436 |
| September 11, 2024 | 4.509 |
| September 10, 2024 | 4.497 |
| September 09, 2024 | 4.437 |
| September 06, 2024 | 4.406 |
| September 05, 2024 | 4.368 |
| September 04, 2024 | 4.412 |
| September 03, 2024 | 4.387 |
| August 30, 2024 | 4.531 |
| August 29, 2024 | 4.527 |
| August 28, 2024 | 4.564 |
| August 27, 2024 | 4.542 |
| August 26, 2024 | 4.537 |
| August 23, 2024 | 4.564 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.235
Minimum
Oct 30 2023
8.039
Maximum
Aug 27 2021
4.797
Average
4.284
Median
Price to Book Value Benchmarks
| AC Immune SA | 2.162 |
| CRISPR Therapeutics AG | 2.182 |
| Addex Therapeutics Ltd | 0.8125 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 1.174 |
Price to Book Value Related Metrics
| PE Ratio | 71.05 |
| PS Ratio | 6.089 |
| Price | 62.99 |
| Earnings Yield | 1.41% |
| Market Cap | 45.43B |
| Operating PE Ratio | 47.30 |
| Normalized PE Ratio | 63.03 |